Gruetter C A, Lemke S M
Can J Physiol Pharmacol. 1986 Nov;64(11):1395-401. doi: 10.1139/y86-236.
The mechanism whereby nitroglycerin relaxes vascular smooth muscle remains uncertain. A current hypothesis suggests that nitroglycerin reacts with critical cellular sulfhydryl groups to form an intermediate, which activates guanylate cyclase, resulting in cGMP accumulation and relaxation. This study investigated further the potential involvement of sulfhydryls in nitroglycerin-induced vascular smooth muscle relaxation by evaluating effects of a variety of sulfhydryl alkylating and reducing agents on responses to nitroglycerin and other relaxants in bovine coronary arterial strips submaximally contracted using 30 mM K. Whereas 10(-4) M 5,5'-dithiobis-(2-nitrobenzoic acid), 10(-5) MN-ethylmaleimide, and 10(-4) MN-naphthylmaleimide did not affect nitroglycerin-induced relaxation, 10(-4) MN-ethylmaleimide and 10(-4) M ethacrynic acid significantly inhibited relaxation induced by nitroglycerin. Both ethacrynic acid and N-ethylmaleimide at 10(-4) M also inhibited relaxation induced by sodium nitroprusside. N-ethylmaleimide, but not ethacrynic acid, inhibited relaxation induced by isoproterenol and forskolin. Ethacrynic acid significantly reduced both relaxation and cGMP elevation induced by both 10(-7) M nitroglycerin and 10(-7) M sodium nitroprusside. Ethacrynic acid, but not N-ethylmaleimide, significantly reduced relaxation induced by 8-Br-cGMP. Pretreatment with the sulfhydryl-containing agents N-acetylcysteine, 2-mercaptoethanol, or dithiothreitol, at 10(-3) M did not affect nitroglycerin-induced relaxation in nontolerant arteries. Similarly, N-acetylcysteine and dithiothreitol did not alter the depressed responses to nitroglycerin in arteries in which tolerance to nitroglycerin was induced in vitro. A slight but statistically significant reversal of nitroglycerin-tolerance occurred after treatment of tolerant arteries with 2-mercaptoethanol.(ABSTRACT TRUNCATED AT 250 WORDS)
硝酸甘油舒张血管平滑肌的机制尚不清楚。目前的一种假说认为,硝酸甘油与关键的细胞巯基反应形成一种中间体,该中间体激活鸟苷酸环化酶,导致环磷酸鸟苷(cGMP)蓄积并引起舒张。本研究通过评估多种巯基烷化剂和还原剂对用30 mM钾使牛冠状动脉条达到亚最大收缩状态时对硝酸甘油和其他舒张剂反应的影响,进一步研究了巯基在硝酸甘油诱导的血管平滑肌舒张中的潜在作用。虽然10⁻⁴ M 5,5'-二硫代双(2-硝基苯甲酸)、10⁻⁵ M N-乙基马来酰胺和10⁻⁴ M N-萘基马来酰胺不影响硝酸甘油诱导的舒张,但10⁻⁴ M N-乙基马来酰胺和10⁻⁴ M依他尼酸显著抑制硝酸甘油诱导的舒张。10⁻⁴ M的依他尼酸和N-乙基马来酰胺也抑制硝普钠诱导的舒张。N-乙基马来酰胺而非依他尼酸抑制异丙肾上腺素和福斯高林诱导的舒张。依他尼酸显著降低10⁻⁷ M硝酸甘油和10⁻⁷ M硝普钠诱导的舒张和cGMP升高。依他尼酸而非N-乙基马来酰胺显著降低8-溴-cGMP诱导的舒张。用10⁻³ M含巯基的药物N-乙酰半胱氨酸、2-巯基乙醇或二硫苏糖醇预处理,对非耐受性动脉中硝酸甘油诱导的舒张无影响。同样,N-乙酰半胱氨酸和二硫苏糖醇也未改变体外诱导对硝酸甘油产生耐受性的动脉中对硝酸甘油降低的反应。用2-巯基乙醇处理耐受性动脉后,出现了轻微但具有统计学意义的硝酸甘油耐受性逆转。(摘要截短至250字)